CellFE

Regenerative Medicine · Cell & Gene Therapy

Facts

as of Nov 18, 2026

We transform the way cell therapies are manufactured to enable affordable advanced treatments for all.

Headquarters
Hayward, United States
Official records
Wikidata Q141670213
Website
cellfebiotech.com

These are the key facts about CellFE on Alion as of Nov 18, 2026. CellFE is headquartered in Hayward, United States. It has raised $26.8M in 2 funding rounds. The latest round is Series A of $22M, announced in 2023.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Hayward United StatesHeadquarters0
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$26.8MTotal raised
$2.9MPublic grants5 public grants
GrantLatest round
7Rounds and grants
Money by yearUSD, rounds and grants
2025$314k1 record
2023$22M1 record
2022$1.7M1 record
2020$5.4M3 records
2019$224k1 record
Largest rounds and grants
$22M
2020
$4.8M
2022
$1.7M
2020
$359k
2025
$314k
Sources: funding announcements, grant and company registers

Milestones

Each milestone is dated by its source: registers, filings, the press

Newsroom

May 13, 20252025
Blog
CellFE and Made Scientific announce a strategic collaboration to generate pilot data on the CellFE High Volume Cyva System. The post CellFE and Made Scientific Announce Strategic…
Apr 30, 20252025
Blog
CellFE, a leader in non-viral gene editing technology, announces a strategic collaboration with the Harbottle Lab at German Cancer Research Center (DKFZ) and its spin-out company…
Mar 4, 20252025
Blog
CellFE releases a cGMP-compatible workflow to support highly efficient gene editing of iPSCs via a non-viral approach for cell therapy manufacturing. The post Application Note: E…
Jan 22, 20252025
News · YahooFinance
CellFE, a leader in non-viral gene editing technology, today announced the launch of its highly anticipated CellFE T-Rest ("Resting T Cell Kit"), a first-in-class cell manufactur…
Jan 17, 20252025
Blog
In the rapidly evolving field of cellular engineering, achieving complex gene edits with high efficiency and minimal workflow disruption remains a significant challenge. The post…
Sources: the outlets named on each headline, each story once